This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Neonatal gynaecomastia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Neonatal gynaecomastia

  • Overall, 65-90% of neonates have breast tissue (1)
    • results from the transfer of maternal and placental oestrogen and progesterone
    • persists up to several months

Notes:

  • neonatal breast enlargement is a normal response to falling levels of maternal estrogen at the end of pregnancy
    • these trigger the release of prolactin from the newborn's pituitary
  • neonatal breast enlargement is common is independent of the sex of the baby
  • generally bilateral - although may not be symmetrical; if unilateral then consider breast abscess; also infective mastitis can occur in a neonate and consider this especially if neonate is unwell and breast enlargement has features of infection (e.g. heat, erythema)
  • usually occurs in the first week of life and generally resolves within a few weeks (2) - but may persist for several months (1)
  • enlarged breast may discharge liquid; this usually resolves without treatment over a period of a few weeks
    • squeezing the breast to facilitate the discharge may lead to irritation, further enlargement, the persistence of the hypertrophied tissue, or, in rare cases, infection (mastitis or abscess)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.